ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
Diabetes News
 > Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Estrogen Level in Pregnancy May Affect Breast Cancer Risk in Daughters
Too much of the hormone can disable tumor suppressor gene, researchers report

TUESDAY, April 9 (HealthDay News) -- Daughters born to women who had excess levels of estrogen during pregnancy may be at increased risk for breast cancer, a new study suggests.

That's because high estrogen levels in the womb can disable the powerful breast cancer tumor suppressor gene BRCA1 in daughters, the researchers at Georgetown Lombardi Comprehensive Cancer Center said in a Georgetown news release.

Their study of 1-year-old girls whose mothers had high estrogen levels during pregnancy also found that the daughters had other gene abnormalities that can contribute to the risk of breast cancer and breast cancer recurrence.

This includes a gene defect in the so-called unfolded protein response pathway, which has been linked to breast cancer risk and resistance to the breast cancer drug tamoxifen.

Although the study found an association between high estrogen levels in pregnancy and factors that raise breast cancer risk in daughters, it did not prove cause and effect.

If the findings are confirmed, they could be used to identify women at increased risk for breast cancer and to lower their risk before the disease develops, the researchers said.

There are drugs available that may make it "possible to reverse the increase in breast cancer risk and prevent development of resistance to tamoxifen in these women," study lead author Leena Hilakivi-Clarke, a professor of oncology at Georgetown Lombardi, said in the news release.

The study was to be presented Tuesday at the American Association for Cancer Research annual meeting, in Washington, D.C. The data and conclusions of research presented at meetings are typically considered preliminary until published in a peer-reviewed medical journal.

More information

Breastcancer.org has more about breast cancer risk.



SOURCE: Georgetown University Medical Center, news release, April 9, 2013

-- Robert Preidt

Health News Copyright © 2013 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS